Techlife Capital

Techlife Capital is a Paris-based growth equity firm founded in 2018. The firm specializes in making growth buy-out investments in companies within the healthcare and technology sectors. By focusing on these industries, Techlife Capital aims to support the development and expansion of innovative businesses that contribute to advancements in health and technology.

Henry Huyghues Despointes

Co-Founder and Senior Partner

Jacques Rossignol

Co-Founder and Managing Partner

2 past transactions

Flash Therapeutics

Debt Financing in 2021
Flash Therapeutics is a biotechnology company based in Labège, France, specializing in gene and cell-based therapies through its proprietary lentiviral platform. Established in 2005 and formerly known as Vectalys SAS, the company focuses on developing advanced viral vector technologies to transduce difficult-to-transfect cells, including primary cells and stem cells. Flash Therapeutics offers a range of services, including gene silencing, gene over-expression, cell-based assay development, and protein expression. It also conducts preclinical trials for gene therapy and produces concentrated viral vectors for research purposes. The company is committed to creating innovative solutions for drug screening and the development of cellular and animal models to validate candidate genes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.